Raymond James Financial Services Advisors Inc. Takes Position in athenahealth, Inc. (ATHN)

Raymond James Financial Services Advisors Inc. acquired a new stake in athenahealth, Inc. (NASDAQ:ATHN) during the second quarter, according to its most recent 13F filing with the SEC. The fund acquired 3,902 shares of the health services provider’s stock, valued at approximately $548,000.

A number of other institutional investors have also recently made changes to their positions in ATHN. Russell Investments Group Ltd. raised its stake in athenahealth by 380.8% in the 1st quarter. Russell Investments Group Ltd. now owns 5,409 shares of the health services provider’s stock valued at $609,000 after acquiring an additional 4,284 shares during the period. UBS Asset Management Americas Inc. raised its stake in athenahealth by 14.0% in the 1st quarter. UBS Asset Management Americas Inc. now owns 22,931 shares of the health services provider’s stock valued at $2,584,000 after acquiring an additional 2,820 shares during the period. Legal & General Group Plc raised its stake in athenahealth by 193.4% in the 1st quarter. Legal & General Group Plc now owns 12,914 shares of the health services provider’s stock valued at $1,455,000 after acquiring an additional 8,513 shares during the period. Dimensional Fund Advisors LP raised its stake in athenahealth by 37.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 121,650 shares of the health services provider’s stock valued at $13,708,000 after acquiring an additional 33,061 shares during the period. Finally, UBS Group AG raised its stake in athenahealth by 145.5% in the 1st quarter. UBS Group AG now owns 8,794 shares of the health services provider’s stock valued at $991,000 after acquiring an additional 28,115 shares during the period.

COPYRIGHT VIOLATION WARNING: “Raymond James Financial Services Advisors Inc. Takes Position in athenahealth, Inc. (ATHN)” was originally published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/11/02/raymond-james-financial-services-advisors-inc-takes-position-in-athenahealth-inc-athn.html.

In other news, SVP Bradford Kyle Armbrester sold 1,000 shares of athenahealth stock in a transaction that occurred on Friday, October 27th. The stock was sold at an average price of $128.56, for a total value of $128,560.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jonathan Bush sold 4,000 shares of athenahealth stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $139.77, for a total value of $559,080.00. Following the completion of the transaction, the chief executive officer now owns 319,807 shares of the company’s stock, valued at approximately $44,699,424.39. The disclosure for this sale can be found here. Insiders have sold a total of 12,783 shares of company stock valued at $1,680,236 in the last 90 days. 3.20% of the stock is currently owned by company insiders.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.06. The business had revenue of $304.60 million during the quarter, compared to analysts’ expectations of $310.52 million. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. The firm’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.60 EPS.

A number of research analysts have weighed in on the company. Piper Jaffray Companies reaffirmed a “buy” rating and set a $152.00 target price on shares of athenahealth in a report on Friday, July 14th. Leerink Swann set a $155.00 target price on athenahealth and gave the company a “hold” rating in a report on Thursday, October 19th. Oppenheimer Holdings, Inc. lifted their target price on athenahealth from $154.00 to $184.00 and gave the company an “outperform” rating in a report on Friday, July 21st. Wells Fargo & Company reaffirmed an “outperform” rating and set a $190.00 target price (up previously from $130.00) on shares of athenahealth in a report on Saturday, July 22nd. Finally, BidaskClub lowered athenahealth from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and eleven have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $143.22.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

What are top analysts saying about athenahealth Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for athenahealth Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit